Skip to main content

Does the Janssen vaccine work against new variants?

In clinical trials, the Janssen (Johnson & Johnson) vaccine has been tested against a variety of COVID-19 virus variants, including B1.351 (also known as Beta-first identified in South Africa), and currently one of four variants in the United States.

The World Health Organization(WHO) Strategic Advisory Group of Experts currently recommends using the Janssen(Johnson & Johnson) vaccine, according to the WHO Prioritization Roadmap, even if variants of concern are present in a country.

As COVID-19 continues to spread in the United States and variants are circulating, here are some steps you can take to protect yourself from the virus:

 

To learn more, please visit: https://www.who.int/news-room/feature-stories/detail/the-j-j-covid-19-vaccine-what-you-need-to-know?gclid=CjwKCAjw-e2EBhAhEiwAJI5jg_83laQuZofLw06GubXGfdOux-1MNImPWWLO4v9Bpfmi3yhbT4y0SRoCRIQQAvD_BwE